KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Short term Debt: 2010-2019

Historic Short term Debt for Emergent BioSolutions (EBS) over the last 5 years, with Dec 2019 value amounting to $3.2 million.

  • Emergent BioSolutions' Short term Debt fell 59.16% to $22.3 million in Q2 2020 from the same period last year, while for Jun 2020 it was $22.3 million, marking a year-over-year decrease of 59.16%. This contributed to the annual value of $3.2 million for FY2019, which is 68.32% down from last year.
  • As of FY2019, Emergent BioSolutions' Short term Debt stood at $3.2 million, which was down 68.32% from $10.1 million recorded in FY2018.
  • In the past 5 years, Emergent BioSolutions' Short term Debt registered a high of $10.1 million during FY2018, and its lowest value of $3.2 million during FY2019.
  • In the last 2 years, Emergent BioSolutions' Short term Debt had a median value of $6.7 million in 2018 and averaged $6.7 million.
  • Data for Emergent BioSolutions' Short term Debt shows a maximum YoY tumbled of 68.32% (in 2019) over the last 5 years.
  • Over the past 2 years, Emergent BioSolutions' Short term Debt (Yearly) stood at $10.1 million in 2018, then slumped by 68.32% to $3.2 million in 2019.